logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
03/11/2026
Zhitong Finance APP News, Dongrui Pharmaceutical (02348.HK) announced that on November 3, 2026, it spent HK$92,500 to repurchase 100,000 shares.
Latest
now
Duality Biotherapeutics-B (09606.HK) repurchased 15,000 shares for HK$1.5059 million on November 3.
1 m ago
Amneal Pharma raises its fiscal year 2026 net revenue guidance.
1 m ago
DuPont expects fourth-quarter net sales of approximately $1.83 billion, versus the market expectation of $1.82 billion.
2 m ago
Lonking Holdings (03339.HK): Wang Xiaobin Appointed Executive Director and President
2 m ago
USD bond movement|Tencent Holdings TENCNT 3.68 04/22/41 price falls 2.454% to 74.231
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.